Filing Flows › Nutra Pharma (NPHC) › Q4 2024
Nutra Pharma (NPHC) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Feb 17, 2026
Nutra Pharma (NPHC) reported revenue of $82K for the fourth quarter 2024 (Q4 2024), +74% from a year earlier and +9% from the quarter before. Operating margin was -218.5%, net loss $231K (282.0% of revenue).
Nutra Pharma, Q4 2024: revenue $82K (+74% year over year), operating margin -218.5%, net loss $231K, operating cash flow −$178K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $82K | +9% | +74% |
| Operating profit | −$179K | — | — |
| Net earnings | −$231K | — | — |
| Operating cash flow | −$178K | — | — |
What changed
Revenue was $82K in Q4 2024, up 74% year over year and up 9% from the previous quarter.
Operating costs exceeded revenue by $179K, an operating margin of -218.5%. Total costs grew 39% against revenue growth of 74%. The quarter ended with a net loss of $231K, narrower than the previous quarter's $261K loss.
Operating cash flow was −$178K. Non-cash charges added back $2K of depreciation. Working capital and other items added $51K.
Questions
What was Nutra Pharma's revenue in the fourth quarter 2024?
Nutra Pharma (NPHC) reported revenue of $82K for the fourth quarter 2024 (Q4 2024), +74% from a year earlier and +9% from the quarter before.
Was Nutra Pharma profitable in the fourth quarter 2024?
Operating loss was $179K (-218.5% of revenue) and net loss $231K.
Source: Nutra Pharma 10-K on SEC EDGAR.